Trials for AstraZeneca’s new ‘antibody cocktail’ treatment will begin in the UK

Trials for AstraZeneca’s new ‘antibody cocktail’ treatment will begin in the UK – and it could prevent Covid-19 from developing for up to a year.  A participant in Manchester will be the first in the world to receive the pharmaceutical company’s new ‘antibody cocktail’ as part of the trial to test its effectiveness. The clinical … Read more

Pfizer coronavirus jab ‘7 times more expensive’ than AstraZeneca’s

Pfizer’s coronavirus vaccine could cost Britain £588million and wind up being seven times more expensive per dose than the one being developed by Oxford University. The jab, which the company this week claimed is 90 per cent effective and could be approved by regulators within weeks, is likely to cost at least £15 per dose … Read more

FDA to let AstraZeneca’s coronavirus vaccine trials resume in the US

US regulators said on Wednesday that AstraZeneca can resume the US arm of its trial of Oxford University’s coronavirus vaccine, according to documents obtained by the Wall Street Journal.  AstraZeneca paused global trials on September 8 due to what it called at the time an ‘unexplained illness’ in a British volunteer.  Tests resumed on September … Read more

Volunteer in AstraZeneca’s coronavirus vaccine trial dies in Brazil

BREAKING NEWS: Volunteer in AstraZeneca and Oxford’s coronavirus vaccine trial dies in Brazil Anvisa, Brazil’s health authority, announced on Wednesday that a volunteer in AstraZeneca and Oxford University’s coronavirus vaccine trial has died Reports indicate the volunteer was a 38-year-old man who did not receive the jab prior to his death    Health officials say he … Read more

Astrazeneca’s US Covid vaccine trial to resume

Astrazeneca’s US Covid trial to resume after regulators fail to link patient’s illness with the vaccine By Daily Mail City & Finance Reporter Published: 22:12 BST, 20 October 2020 | Updated: 22:32 BST, 20 October 2020 Astrazeneca’s large, late-stage US trial has been on hold since September 6 Astrazeneca’s Covid-19 vaccine trial in the United … Read more

US widens probe into Astrazeneca’s Covid jab after patient falls ill

US widens probe into Astrazeneca’s Covid jab after patient develops rare spinal disorder during trials By Daily Mail City & Finance Reporter Published: 21:52 BST, 1 October 2020 | Updated: 22:05 BST, 1 October 2020 A probe into how a patient became ill during trials of Astrazeneca’s potential Covid-19 jab has been widened in the … Read more

US regulators are ‘very concerned’ about the side effects of AstraZeneca’s vaccine

US regulators are ‘very concerned’ about the potential side effects of AstraZeneca and Oxford University’s coronavirus vaccine and are debating whether or not to allow the trials to resume. Last week, the trial was put on hold when a British participant was rushed to the hospital after suffering a serious reaction that triggered spinal cord … Read more

Oxford and AstraZeneca’s COVID vaccine trial could restart ‘within days’

Trials of Oxford University’s coronavirus vaccine could be allowed to restart just days after a British volunteer was rushed to hospital with suspected swelling in their spinal cord. UK drug giant AstraZeneca, which owns the rights to the vaccine, announced that all studies of the jab had been paused indefinitely while it investigates whether the … Read more

Oxford and AstraZeneca’s COVID vaccine trial could restart ‘within days’

Trials of Oxford University’s coronavirus vaccine could be allowed to restart just days after a British volunteer was rushed to hospital with suspected swelling in their spinal cord. UK drug giant AstraZeneca, which owns the rights to the vaccine, announced that all studies of the jab had been paused indefinitely while it investigates whether the … Read more

AstraZeneca’s COVID-19 vaccine trials put on hold after suspected ‘serious’ reaction

Oxford and AstraZeneca’s COVD-19 vaccine trial is put on HOLD for safety reasons after a British volunteer had a ‘serious’ reaction that could have been caused by injection Late stage trials for the vaccine being developed by AstraZeneca and Oxford University have been put on hold  A ‘serious adverse event,’ a possible reaction to the … Read more